English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 24, 2024

Study identifies new therapeutic targets expanding options for treating various cancers

+ Pharmaceuticals
Patient Daily | Jun 24, 2024

McGovern Medical School's JAMP supports aspiring medical students

+ Pharmaceuticals
Patient Daily | Jun 24, 2024

Oral Health Foundation unveils comprehensive plan for UK dental care reform

+ Pharmaceuticals
Patient Daily | Jun 21, 2024

UTHealth Houston receives $2.4M NIH grant for cluster headache research

+ Pharmaceuticals
Patient Daily | Jun 21, 2024

Baylor expert highlights factors impacting male fertility

+ Pharmaceuticals
Patient Daily | Jun 21, 2024

American Lung Association condemns FDA's authorization of menthol e-cigarettes

+ Pharmaceuticals
Patient Daily | Jun 21, 2024

Court limits ruling on no-cost preventive screenings but leaves future uncertain

+ Pharmaceuticals
Patient Daily | Jun 20, 2024

Mayo Clinic launches podcast to highlight medical innovations

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 279
  • 280
  • 281
  • 282
  • 283
  • 284
  • 285
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily